发作性睡病由法国医生Gelineau在1880年首次提出,在国际上被认为罕见病,已列入我国《第二批罕见病目录》 ,国内大约有50-70万患者。我国发病高峰年龄为8-12岁,可发生在幼儿阶段,从发病到确诊平均延迟8-22年,贯穿儿童求学和个性发展关键时期,是一种终身性疾病,给患者及家庭带来严重负担,特别对儿童和青少年群体。
本综述深入探讨了发作性睡病(Narcolepsy)的临床表现、治疗策略及未来方向,强调需超越经典五联征进行综合管理。 发作性睡病(Narcolepsy)是一种罕见的慢性神经学疾病,其特征性症状包括白天过度嗜睡(Excessive Daytime Sleepiness, EDS)、猝倒(Cataplexy)、夜间 ...
Narcolepsy is a nervous system disorder that involves your brain. You struggle to manage sleep patterns and stay awake. No matter how much rest you got the night before, an intense urge to sleep ...
Stackhouse was diagnosed with narcolepsy during his first year at Georgia, where he started 42 games and won two national ...
Increased levels of Tribbles homolog 2 (TRIB2) autoantibodies, which specifically target hypocretin neurons, have been observed in patients with narcolepsy, and high levels of these antibodies ...
Multiple sleep disorders can affect your energy levels, and two that often get confused for one another are narcolepsy and chronic fatigue syndrome. Though both chronic fatigue syndrome and ...
This isn’t the case when you have narcolepsy with cataplexy. Narcolepsy is a chronic condition that happens when you don’t have enough neurons that make orexins. People with narcolepsy are ...
Centessa Pharmaceuticals plc shifts focus to ORX750 for sleep disorders after discontinuing SerpinPC. Click here to find out ...
I am delighted to serve as guest editor for the recently published CNS Drugs supplement, focused on key clinical issues for people with narcolepsy and their clinicians with a particular emphasis on ...
2 天
Zacks Investment Research on MSNAXSM Stock Down on Top-Line Data From Depression Study on SolriamfetolAxsome Therapeutics AXSM announced top-line data from the phase III PARADIGM study, which evaluated solriamfetol for the treatment of major depressive disorder (MDD) with and without severe excessive ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果